An optimized synthetic route for mirogabalin besylate(1), a drug for the treatment of diabetic neuropathic pain in adults, was developed using 3-ethylbicyclo[3.2.0]hept-3-ene-6-one(2) as the starting material. The process involved chemical resolution, Wittig-Horner reaction, Michael addition, nitro reduction, secondary resolution,deprotection, and salt formation. In this optimal route, key improvements included enhancing the chiral resolution method and optimizing the nitro reduction step, which mitigated safety risks from Raney nickel hydrogenation. The overall yield increased from 8% to 10.2% (based on 2), with HPLC purity of the targeted compound reaching 99.2%. Featuring simple operation and reliable product quality, this route is suitable for industrial production.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |